Tag: inhibitors

CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off

CRTAM inhibition mitigates toxicity of immune checkpoint inhibitors without antitumor efficacy trade-off

Reck, M., Remon, J. & Hellmann, M. D. First-line immunotherapy for non-small-cell lung cancer. J. ...

READ MORE
Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy

Beyond suppression: the paradox of JAK inhibitors as amplifiers of cancer immunotherapy

Mumm, J. B. et al. IL-10 elicits IFNγ-dependent tumor immune surveillance. Cancer Cell 20, 781–796 ...

READ MORE